JCR Pharmaceuticals Co., Ltd.

Some 10 years since Japan introduced policies, regulations and review pathways to encourage the development and commercialization of cell therapy products, the country has recently modified some regul

Some 10 years since Japan introduced policies, regulations and review pathways to encourage the development and commercialization of cell therapy products, the country has recently modified some regul

Some 10 years since Japan introduced policies, regulations and review pathways to encourage the development and commercialization of cell therapy products, the country has recently modified some regul

Regenxbio Inc. is a step closer to bringing its mucopolysaccharidosis type II (MPS II) gene therapy to market following a pivotal win in the CAMPSIITE trial. But the study only assessed the effect of